Status and phase
Conditions
Treatments
About
Clinical trial for the novo transplant recipients, which aims to assess tolerability and safety and clinical outcomes of EC-MPS in combination with cyclosporine microemulsion (CsA-ME) with or without steroids in a population of kidney transplant recipients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other inclusion/exclusion criteria may apply
Primary purpose
Allocation
Interventional model
Masking
30 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal